FDA, opioid

FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
FDA approves 1st new class of opioid-free painkillers in over 20 years
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.
FDA Approves First New Non-Opioid Pain Pill in Decades
FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.
Vertex Pharmaceuticals' non-opioid pain medication gets FDA approval
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA).
FDA Approves the First Non-Opioid Pain Drug in 20 Years
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non-opioid painkiller since that class first appeared on the market in the 1980s.
What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.
Vertex Pharmaceuticals Shares Gain After FDA Approves Non-Opioid Pain Drug
Shares of Vertex Pharmaceuticals rose after Journavx, the company’s oral non-opioid pain medication, received Food and Drug Administration approval.

FDA, recall and Chocolate

Hosted on MSN10h
FDA approves 'ketamine' nasal spray for depression — here's everything you need to know
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
What is Non-Opioid Pain Medication? Journavx Approved by FDA
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
FDA sounds alarm on 'potentially deadly' Bay Area chocolate
The Food and Drug Administration has elevated three chocolates made by a Fairfield manufacturer to the highest-level recall classification.
clickondetroit.com4h
Hyperbaric chambers: What they are, what they treat, risks, and accreditation
Here's what to know about hyperbaric chambers after a 5-year-old boy was killed in an explosion at a healthcare facility in ...
News Medical4h
New FDA initiatives focus on medication safety for pregnant and nursing women
If you are pregnant or nursing, talk with your health care professional about whether to enroll in pregnancy safety or ...
Trump's tariffs, American Airline crash, DeepSeek's AI crash
Trump’s White House juggled a devastating American Airline flight-Black Hawk helicopter crash, a Chinese AI threat and looming tariffs just this week alone, making for a busy start to his four-year ...
Pet Food Recall Prompts Warning in Eight States
The raw dog food product was distributed between January 3 and 24 in retail stores in eight states: Virginia, Maryland, Pennsylvania, Connecticut, Massachusetts, New York, Tennessee and Rhode Island.
verywellhealth8h
6 Takeaways From RFK Jr.'s Confirmation Hearing: From Vaccines To Medicaid
As secretary of the HHS, Kennedy would oversee major health agencies, including the Food and Drug Administration (FDA), the ...